A new international study has delivered a rare dose of good news in the fight against aggressive brain tumors. Researchers ...

Intellia Therapeutics has temporarily paused dosing and screening in a pair of phase 3 trials in response to a liver safety signal. Shares in Intellia fell 44% to $14.34 in early trading Monday. The ...

A model of Taiwanʼs Indigenous Defense Submarine at the Taipei Aerospace & Defense Technology Exhibition 2025. (Janes/Akhil Kadidal) Efforts to conclude sea trials of Taiwan's Indigenous Defense ...

Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...

Passage Bio reports positive Phase 1/2 trial results for PBFT02 in frontotemporal dementia, with planned protocol amendments for safety optimization. Passage Bio, Inc. announced positive results from ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...

Clinical trials move through four structured phases, from safety testing to long-term effects. Adaptive, basket, and umbrella trials are making cancer research faster and more flexible. Molecular ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The replicate, multicenter, randomized, double-blind, ...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq: INCY) today announced positive topline results from its pivotal Phase 3 STOP-HS clinical trial program evaluating the safety and efficacy of ...

• The basis of phases segment, the market includes phase I, phase II, phase III & phase IV. In 2024, the phase III segment dominated the market, accounting for a revenue share of 48.43%. • The phase I ...

CEO Shawn Singh outlined the company’s progress on its lead clinical programs, particularly fasedienol, which is being developed for the acute treatment of social anxiety disorder (SAD). Singh ...